In line with previous observations in patients with mesothelioma (20, 21), we reveal that Merlin status may also predict for FAKi sensitivity in PDAC, and on the basis of our preclinical data using patient-derived assessment, this may warrant further investigation. This evidence concerns the gene NF2 and mesothelioma.